1. Home
  2. RNAZ vs AMBO Comparison

RNAZ vs AMBO Comparison

Compare RNAZ & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

N/A

Current Price

$9.34

Market Cap

8.5M

Sector

Health Care

ML Signal

N/A

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

N/A

Current Price

$2.11

Market Cap

7.2M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
RNAZ
AMBO
Founded
2016
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
8.5M
7.2M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
RNAZ
AMBO
Price
$9.34
$2.11
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$280.00
N/A
AVG Volume (30 Days)
8.7K
10.2K
Earning Date
11-14-2025
08-05-2025
Dividend Yield
N/A
N/A
EPS Growth
54.50
337.04
EPS
N/A
0.02
Revenue
N/A
$9,469,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$88.98
Revenue Growth
N/A
0.82
52 Week Low
$0.22
$1.47
52 Week High
$20.99
$6.75

Technical Indicators

Market Signals
Indicator
RNAZ
AMBO
Relative Strength Index (RSI) 46.26 50.85
Support Level $8.47 $1.47
Resistance Level $9.70 $3.15
Average True Range (ATR) 0.68 0.17
MACD -0.06 0.08
Stochastic Oscillator 27.43 73.49

Price Performance

Historical Comparison
RNAZ
AMBO

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: